![](/img/cover-not-exists.png)
35 CONVERT-A multicentre randomised controlled NCRN trial comparing accelerated twice-daily and high dose once-daily thoracic radiotherapy in good performance status (PS), limited small-cell lung cancer (LD SCLC) treated concurrently with cisplatin and etoposide
Faivre-Finn, C., Lorigan, P., Blackhall, F., Ashcroft, L., Lyn, E., Lee, M., McMenemin, R., Mohammed, N., Price, A., Stephens, R., Snee, M., VanMeerbeck, J., Woll, P.Volume:
57
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(07)70361-6
Date:
August, 2007
File:
PDF, 45 KB
english, 2007